About
Pressroom
Resources
Get Updates
Issues
Access to Medicines
Funding the Fight
Health Justice
Transparency & Accountability
PEPFAR Watch
Blog
Our Impact
Take Action
Do something now
DONATE
Blog
Access to Medicines
Merck’s Molnupiravir – Overcoming impending barriers to affordable global access
Access to Medicines
Biggest Roadblock to Biden-Convened COVID-19 Summit’s Success: Fealty to Moderna and Pfizer
COVID-19
The Global Fund: A Foundation for Health Equity
Access to Medicines
Biden’s $2.7 billion investment in supply chains is a cynical boost to Big Pharma’s continued control over...
Health Justice
Our Shared Struggles for Health Justice
Access to Medicines
The European Union, Led by Germany’s Chancellor Merkel, Chokes Off Progress on Intellectual Property Waiver ...
Access to Medicines
Disinformation, Diversion, and Delay: The Real Text of the European Union’s Communication to the WTO TRIPS C...
Access to Medicines
The Impracticality of Relying on Compulsory Licenses to Expand Production Capacity for COVID-19 Vaccines
Health Justice
Honor the Dead, Fight Like Hell for the Living
Access to Medicines
Debunking Pharma’s Talking Points on the TRIPS Waiver
Access to Medicines
Securing the TRIPS Waiver the World Needs: What Comes Next?
PEPFAR Watch
Sentayi and Maureen
Access to Medicines
Pfizer and BioNTech Profiteering Exposed – More than Enough is Enough
Funding the Fight
Now more than ever, countries need increased PEPFAR resources for an effective HIV response
Access to Medicines
Biden Can’t Correct Vaccine Apartheid on Big Pharma’s Terms
SEE MORE
